Week 76 Review - Optibiotix Soars

Another week like last week, with small gains causing the portfolio to close the gap towards profit. The other similarity to last week is that OPTI:Optibiotix has climbed 9% for the second week in a row and finally seems to have broken out of the downward spiral. The climb and the fact I bought more whilst at a lower price means my loss on this share has narrowed from over £1,000 to just £494. Not only does this remove the title of Nemesis Share, but there are 6 shares losing more than Optibiotix now. The next few weeks could be spectacularly exciting for this company. So much is on the cusp of happening after a long wait over the last 12 months.

The new Nemesis Share is AFG:Aquatic Food which is losing £879. I still think this is a sound company, but nobody else does. I'm nervous about adding more while at this level in case I'm wrong, and if I'm nervous as a holder it explains why others are reluctant to buy in. A few more years of dividends and maybe a takeover of another company may help improve sentiment.

Worst performer of the week was my birthday present to myself. REDS:RedstoneConnect surged on news that it had won a huge contract to fit out a smart office for a major tech firm. The feeling is that the tech firm is Google, so the share price shot up. I dived in after adding another £500 to my trading account, expecting it to continue upwards for a few days. Guess what - it didn't! The curse of the trading account struck again and it's gone down 14% when you take spread and commission into account. Bugger!

The other double digit losers were ARL:Atlantis Resources which dropped 12% after last week's 20% rise made it Share of the Week. That didn't last, but I'm hoping it was short term profit taking and this will continue to climb back into profit. RED:RedT Energy dropped 12% too, and seems rather volatile at the moment.

First double-digit riser was CWR:Ceres Power which climbed 11% after recent inexplicable declines. Share of the Week is BMN:Bushveld Minerals which rocketed 49% and is 65% up after just a few weeks with £492 potential profit. I think people have realised that the purchase of the vanadium electrolyte company is a game changer, because these batteries are going to be just as important as lithium, if not more so, and vanadium isn't a common commodity.

Here's the performance of the ISA and share account

			Weekly Change
Portfolio cost	£41,931.83		+£0
Portfolio sell value (bid price - commission)	£37,186.90	(-11.3%)	+£176.19
Potential profits	£1,718.40		+£51.29
Yr 2 Dividends	£264.04		+£0
Yr 2 Profit from sales	£2,845.33		+£0
Yr 2 Average monthly cash profit	£558.03		-£24.26
Yr 2 Avg annual % of current portfolio cost	16%
Total Dividends	£931.97		+£0
Total Profit from sales	£6,685.59		+£0
Average monthly cash profit	£429.83		-£5.73
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	12.3%

The small rise was largely thanks to OPTI:Optibiotix reducing losses, so a much smaller rise in potential profits as things waxed and waned. No sales or dividends so the average monthly performance creeps down. It's weeks until the percentage return gets anywhere near the target 10% so no pressure to sell anything.

 A slow, steady closing of the gap is better than a sudden widening, but there's a long way to go yet.

The SIPP looks like this after week 60.

			Weekly Change
Portfolio cost	£15,919.91		+£0
Portfolio sell value (bid price - commission)	£19,172.33	(+20.4%)	+£268.22
Potential profits	£3,505.68		+£234.98
Yr 2 Dividends	£0		+£0
Yr 2 Profit from sales	£0		+£0
Yr 2 Average monthly cash profit	£0		+£0
Yr 2 Avg annual % of current portfolio cost	0%
Total Dividends	£413.19		+£0
Total Profit from sales	£2,349.86		+£0
Average monthly cash profit	£194.90		-£3.31
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	14.7%

Great rise in profits mainly down to BMN:Bushveld Minerals, offset by the drop in ALM:Allied Minds. The losses narrowed courtesy of OPTI:Optibiotix, but this was offset by ARL:Atlantis Resources dropping. Key metric is that the paper profits have exceeded 20% of the portfolio cost - amazing! No sales or dividends so the average monthly profit dips a little but a long way from the 10% target so no pressure to sell for a long time.

 Very nice - will it keep going?

The trading account looks like this on its 6-month aniversary

			Weekly Change
Portfolio cost	£986.00		+£486.05
Cash	£14.00		+£13.95
Portfolio sell value (bid price - commission)	£918.70	(-6.8%)	-£65.74
Potential profits	£0		+£0
Dividends	£0		+£0
Profit from sales	£0		+£0
Average monthly cash profit	£0		+£0
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost	0%

My birthday pressie to me was £500 to try and inject some life into this account. I used it to buy 27,888 shares of REDS:RedstoneConnect at 1.7p costing £486.05. It meant £13.95 was left over, because I had to leave a limit order as no quotes were available online. You can't state a cash amount for a limit order, and as the price was higher when I left the order it meant I wasn't able to buy as many as I wanted. The offer price has only dipped to 1.65p so not very much at all given there's been lots of short term profit taking. The bid price is only 1.55p so that's why the loss is showing so much. I'm hopefull this has further upwards to go before it settles, and am aiming for 25% profit before selling. Unsurprisingly, SLP:Sylvania Platinum stayed the same, but that's better than dropping, so with results imminent I may be able to take some profit from this account soon.

Nice to see some action on this graph, even if it did cost me £500!

That's it for this week - all eyes on OPTI:Optibiotix next week as things really start to hot up, and JLP:Jubilee Platinum are due to give an update on Hernic. Given that it's stayed above 4p this week, there's some degree of hope.